Enzastaurin Versus Lomustine in Glioblastoma

NCT00295815 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

397

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: enzastaurin
DRUG: lomustine

Sponsor

Eli Lilly and Company